COMMUNIQUÉS West-GlobeNewswire

Aurora Spine Announces Launch of its DEXA-L™ Anterior Lumbar Interbody Fusion Device
18/09/2025
Please click here to view image CARLSBAD, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional [...]
Are Women on the Frontline of Antimicrobial Resistance?
17/09/2025
LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- National Patient Survey of Women’s Urinary Tract Infection (UTI) and Prenatal Screening reveals women suffering from UTI concerned about immediate antibiotic prescribing and [...]
Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update
17/09/2025
REDWOOD CITY, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today [...]
Vaxart Appoints W. Mark Watson as Lead Independent Director
17/09/2025
In process of adopting a Director stock ownership policy to reinforce commitment of aligning the Board’s interests with stockholders Vaxart encourages all stockholders of record on July 29, 2025, who have not yet voted [...]
Regional Health Properties, Inc. Completes Repurchases of 12.5% Series B Cumulative Redeemable Preferred Shares
17/09/2025
Atlanta, GA, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB) (OTCQB: RHEPZ) today announced it has completed the repurchase of 366,359 shares [...]
NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1
17/09/2025
Les données ont montré un profil de sécurité favorable et des signaux préliminaires d’efficacité dans une population lourdement prétraitée dont le cancer était en progression malgré plusieurs lignes de traitement, [...]
NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1
17/09/2025
Data show a favorable safety profile and early efficacy signals in a heavily pre-treated population whose cancer progressed after multiple prior lines of therapy including anti-PD-1 Recommended phase 2 dose (RP2D) [...]
Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM
17/09/2025
CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that 48-week clinical data from the [...]
CooperCompanies Announces Expanded Share Repurchase Program
17/09/2025
SAN RAMON, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today its Board of Directors has approved a $1 billion increase in the Company’s [...]
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
17/09/2025
Postpartum depression is a leading cause of maternal mortality in Europe 1-2 , and is one of the most common medical conditions associated with pregnancy 3-5 ; up to 20% of women experience postpartum depressive [...]
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation
17/09/2025
Arvinas and Pfizer plan to jointly select third party for the out-licensing and commercialization of vepdegestrant Additional cost optimization measures expected to realize total annual savings of more than $100 million [...]
Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
17/09/2025
WOODCLIFF LAKE, N.J., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced the availability of proxy materials for its 2025 Annual Meeting of [...]
Bionano Genomics, Inc. Announces Closing of $10 Million Public Oﬀering
17/09/2025
SAN DIEGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) (“Bionano” or the “Company”) today announced the closing of its previously announced public offering of an aggregate of 5,000,000 [...]
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
17/09/2025
Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy ® ) achieved significant weight loss, with one in three study participants losing 20% or more body weight 1 ** Oral semaglutide 25 mg also demonstrated [...]
Esteworld Concludes Four-Day Consultation Series at Covent Garden, London
17/09/2025
Photo: Esteworld Representative Office - Covent Garden, London LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Esteworld Health Group has concluded a four-day series of face-to-face consultation sessions at its Covent Garden [...]
Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge
17/09/2025
Representing 10 U.S. states and Puerto Rico, finalists will compete in Washington, D.C., for more than $100,000 in awards WASHINGTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Society for Science today announced the 30 [...]
Amid 7-OH Health Warnings, Happy Go Leafy Introduces Pure Kratom Line for Safer Wellness
17/09/2025
Happy Go Leafy responds to 7-OH concerns with a new pure kratom line. Lab-tested and transparent products designed to support safer wellness use. Miami, Florida, Sept. 17, 2025 (GLOBE NEWSWIRE) -- 2025 has seen urgent [...]
The Association of American Physicians and Surgeons (AAPS) Supports HHS Secretary Kennedy and Making America Healthy Again (MAHA)
17/09/2025
TUCSON, Ariz., Sept. 17, 2025 (GLOBE NEWSWIRE) -- On September 13, at its 82 nd annual meeting in Chantilly, VA, the Association of American Physicians and Surgeons (AAPS) passed the following emergency resolution, [...]
Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
17/09/2025
NEEDHAM, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]

Pages